{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:56:45Z","timestamp":1793861805901,"version":"4.6.1"},"reference-count":42,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ischemic priapism is a common but underrecognized morbidity affecting about 33% of adult men with sickle cell disease (SCD). The onset of priapism occurs in the prepubertal period and tends to be recurrent with increasing age. Significantly, priapism is associated with an unrecognized high burden of mental duress and sexual dysfunctions. The diagnosis of priapism is clinical. Many episodes of priapism will resolve spontaneously, but when an episode lasts longer than 4 hours, the episode is considered a urologic emergency requiring quick intervention with either corporal aspiration or shunt surgery. Only 3 randomized clinical trials (stilbesterol, ephedrine or etilefrine, and sildenafil) have been conducted for secondary priapism prevention in SCD. All 3 trials were limited with small sample sizes, selection biases, and inconclusive results after completion. The current molecular understanding of the pathobiology of priapism suggests a relative nitric oxide (NO) deficiency secondary to chronic hemolysis in SCD and associated phosphodiesterase type 5 dysregulation. We posit an increase in NO levels will restore the normal homeostatic relationship between voluntary erection and detumescence. Currently, 2 randomized phase 2 trials (1 double-blind, placebo-controlled trial and 1 open-label, single-arm intervention) are being conducted for secondary priapism prevention in men at high risk for recurrent priapism (NCT03938454 and NCT05142254). We review the epidemiology and pathobiology of priapism, along with mechanistic therapeutic approaches for secondary prevention of priapism in SCD.<\/jats:p>","DOI":"10.1182\/hematology.2022000380","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:12:15Z","timestamp":1670602335000},"page":"450-458","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":49,"title":["Epidemiology and treatment of priapism in sickle cell disease"],"prefix":"10.1182","volume":"2022","author":[{"given":"Ibrahim M.","family":"Idris","sequence":"first","affiliation":[{"name":"1 Department of Haematology, Aminu Kano Teaching Hospital\/Bayero University, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[{"name":"2 School of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"DeBaun","sequence":"additional","affiliation":[{"name":"3 Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"14","key":"2022120916091380700_hem2022000380C1","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/bloodadvances.2020002062","article-title":"Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease","volume":"4","author":"Idris","year":"2020","journal-title":"Blood Adv"},{"key":"2022120916091380700_hem2022000380C2","doi-asserted-by":"crossref","first-page":"eAO5070","DOI":"10.31744\/einstein_journal\/2020AO5070","volume":"18","author":"Alvaia","year":"2020","journal-title":"Einstein (Sao Paulo)"},{"issue":"1","key":"2022120916091380700_hem2022000380C3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/hematology.2021000275","article-title":"Treatment dilemmas: strategies for priapism, chronic leg ulcer disease, and pulmonary hypertension in sickle cell disease","volume":"2021","author":"Azbell","year":"2021","journal-title":"Hematology"},{"issue":"2","key":"2022120916091380700_hem2022000380C4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.21037\/tau.2017.01.18","article-title":"Advances in the understanding of priapism","volume":"6","author":"Hudnall","year":"2017","journal-title":"Transl Androl Urol"},{"issue":"12","key":"2022120916091380700_hem2022000380C5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jsxm.2019.09.012","article-title":"Clinical and genetic predictors of priapism in sickle cell disease: results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study","volume":"16","author":"Cintho Ozahata","year":"2019","journal-title":"J Sex Med"},{"issue":"2","key":"2022120916091380700_hem2022000380C6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bju.13717","article-title":"Guideline of guidelines: priapism","volume":"119","author":"Muneer","year":"2017","journal-title":"BJU Int"},{"key":"2022120916091380700_hem2022000380C7","first-page":"10","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients and non- ischemic priapism: an AUA\/SMSNA guideline","volume":"10","author":"Bivalacqua","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"2022120916091380700_hem2022000380C8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MPH.0000000000002056","article-title":"Psychometric impact of priapism on lives of adolescents and adults with sickle cell anemia: a sequential independent mixed-methods design","volume":"44","author":"Idris","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2022120916091380700_hem2022000380C9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jsxm.2020.11.017","article-title":"Patient education is associated with reduced delay to presentation for management of ischemic priapism: a retrospective review of 123 men","volume":"18","author":"Dutta","year":"2021","journal-title":"J Sex Med"},{"issue":"2","key":"2022120916091380700_hem2022000380C10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/03630269.2018.1452760","article-title":"Prevalence and characteristics of priapism in sickle cell disease","volume":"42","author":"Arduini","year":"2018","journal-title":"Hemoglobin"},{"issue":"5","key":"2022120916091380700_hem2022000380C11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape","volume":"24","author":"Musicki","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"2022120916091380700_hem2022000380C12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2019.11.013","article-title":"Rare disorders of penile erection","volume":"113","author":"Burnett","year":"2020","journal-title":"Fertil Steril"},{"issue":"1","key":"2022120916091380700_hem2022000380C13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/FAD.0000000000000048","article-title":"Drug-induced priapism","volume":"322","author":"Pucci","year":"2020","journal-title":"Adverse Drug React Bull"},{"issue":"20","key":"2022120916091380700_hem2022000380C14","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1182\/blood-2016-12-755777","article-title":"Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa","volume":"130","author":"Dubert","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2022120916091380700_hem2022000380C15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1756287214542096","article-title":"Management of priapism: an update for clinicians","volume":"6","author":"Levey","year":"2014","journal-title":"Ther Adv Urol"},{"issue":"1","key":"2022120916091380700_hem2022000380C16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sxmr.2019.01.001","article-title":"Management of priapism: a contemporary review","volume":"8","author":"Mishra","year":"2020","journal-title":"Sex Med Rev"},{"issue":"4","key":"2022120916091380700_hem2022000380C17","first-page":"464","article-title":"Rare emergency in children: priapism and step-wise treatment approach","volume":"28","author":"Karag\u00f6zl\u00fc Akg\u00fcl","year":"2022","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"issue":"3","key":"2022120916091380700_hem2022000380C18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.sxmr.2018.10.007","article-title":"A systematic review on ischemic priapism and immediate implantation: do we need more data?","volume":"7","author":"Capece","year":"2019","journal-title":"Sex Med Rev"},{"issue":"6","key":"2022120916091380700_hem2022000380C19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(05)81954-7","article-title":"Neurologic events after partial exchange transfusion for priapism in sickle cell disease","volume":"120","author":"Rackoff","year":"1992","journal-title":"J Pediatr"},{"issue":"5, pt 1","key":"2022120916091380700_hem2022000380C20","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0022-5347(17)35817-2","article-title":"Association of sickle cell disease, priapism, exchange transfusion and neurological events: aspen syndrome","volume":"150","author":"Siegel","year":"1993","journal-title":"J Urol"},{"issue":"1","key":"2022120916091380700_hem2022000380C21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jca.21394","article-title":"Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease","volume":"31","author":"Ballas","year":"2016","journal-title":"J Clin Apher"},{"issue":"8","key":"2022120916091380700_hem2022000380C22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"key":"2022120916091380700_hem2022000380C23","article-title":"Incidence and predictors of priapism events in a sickle cell anemia: a diary-based analysis [published online ahead of print 11 July 2022","author":"Idris","journal-title":"Blood Adv"},{"key":"2022120916091380700_hem2022000380C24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004198.pub4","article-title":"Treatments for priapism in boys and men with sickle cell disease","author":"Chinegwundoh","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2022120916091380700_hem2022000380C25","first-page":"10","article-title":"Regimented phosphodiesterase type 5 inhibitor use reduces emergency department visits for recurrent ischemic priapism","volume":"11","author":"Hou","year":"2020","journal-title":"J Urol"},{"issue":"7","key":"2022120916091380700_hem2022000380C26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"issue":"4","key":"2022120916091380700_hem2022000380C27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2022120916091380700_hem2022000380C28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ejh.13612","article-title":"Long-term tolerability of phosphodiesterase-5 inhibitors in pulmonary hypertension of sickle cell disease","volume":"107","author":"Cramer-Bour","year":"2021","journal-title":"Eur J Haematol"},{"issue":"8","key":"2022120916091380700_hem2022000380C29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1590\/1806-9282.63.08.689","article-title":"Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism","volume":"63","author":"Nardozza","year":"2017","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"9","key":"2022120916091380700_hem2022000380C30","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/acem.13822","article-title":"Resolution of acute priapism in two children with sickle cell disease who received nitrous oxide","volume":"26","author":"Greenwald","year":"2019","journal-title":"Acad Emerg Med"},{"issue":"4","key":"2022120916091380700_hem2022000380C31","first-page":"518","article-title":"Effect of hydroxyurea on priapism in men with sickle cell disease","volume":"66","author":"Morrison","year":"2017","journal-title":"West Indian Med J"},{"issue":"1","key":"2022120916091380700_hem2022000380C32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21037\/tau.2019.07.15","article-title":"Dutasteride in the long-term management of stuttering priapism","volume":"9","author":"Baker","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"5","key":"2022120916091380700_hem2022000380C33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S1677-55382012000500014","article-title":"Finasteride for recurrent priapism in children and adolescents: a report on 5 cases","volume":"38","author":"Barroso","year":"2012","journal-title":"Int Braz J Urol"},{"issue":"5","key":"2022120916091380700_hem2022000380C34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/1389450115666141111111842","article-title":"Molecular pathophysiology of priapism: emerging targets","volume":"16","author":"Anele","year":"2015","journal-title":"Curr Drug Targets"},{"issue":"4","key":"2022120916091380700_hem2022000380C35","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1743-6109.2007.00715.x","article-title":"Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient","volume":"5","author":"Davila","year":"2008","journal-title":"J Sex Med"},{"issue":"6","key":"2022120916091380700_hem2022000380C36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jemermed.2017.01.055","article-title":"Recurrent priapism gone wrong: ST-elevation myocardial infarction and cardiogenic shock after penile corporal phenylephrine irrigation","volume":"52","author":"Constantine","year":"2017","journal-title":"J Emerg Med"},{"issue":"7","key":"2022120916091380700_hem2022000380C37","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.STR.0000075293.45936.FA","article-title":"Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs","volume":"34","author":"Cantu","year":"2003","journal-title":"Stroke"},{"issue":"9","key":"2022120916091380700_hem2022000380C38","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.04.018","article-title":"Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature","volume":"23","author":"Tark","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2022120916091380700_hem2022000380C39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1017\/cem.2018.3","article-title":"Management of priapism with a trial of exercise in the emergency department","volume":"21","author":"Gravel","year":"2019","journal-title":"CJEM"},{"issue":"4","key":"2022120916091380700_hem2022000380C40","first-page":"540","article-title":"Endothelial function and physical exercise","volume":"111","author":"Pagan","year":"2018","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"2022120916091380700_hem2022000380C41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/antiox11020350","article-title":"Effects of exercise training on the autonomic nervous system with a focus on anti-inflammatory and antioxidants effects","volume":"11","author":"Daniela","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"2022120916091380700_hem2022000380C42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/450\/2021923\/450idris.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/450\/2021923\/450idris.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:12:38Z","timestamp":1670602358000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2022\/1\/450\/493551\/Epidemiology-and-treatment-of-priapism-in-sickle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2022000380","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,9]]},"published":{"date-parts":[[2022,12,9]]}}}